观点飞利浦

Philips’ investors can ill-afford another jolt to their nerves
Lex专栏:飞利浦投资者的神经承受不起再次刺激

Investors in the Dutch healthcare conglomerate had until this week been enjoying a restorative patch
直到本周,这家荷兰医疗集团的投资者一直过得不错。

Some companies, it seems, receive the benefit of the doubt even if their performance is a little ho-hum. They can, for example, highlight weak Chinese demand and get away with a mere share price ripple. Other stocks take a razor-sharp cut on every lump and bump. 

有些公司似乎即使业绩平平也能得到宽容。例如,它们可以强调manbetx3.0 需求疲软,而只受到股价微小波动的影响。而其他股票则在每一次起伏中都遭受严重打击。

您已阅读10%(333字),剩余90%(3074字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归manbetx20客户端下载 所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×